📰 Adherence News
Page 49 - Adherence News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Adherence. Real-time updates on events, politics, business and more.
February 8, 2024
Health care professionals discuss navigating challenges in opioid management, emphasizing a patient-centric approach, and address barriers and differences among opioid misuse, abuse, and use disorder.
February 1, 2024
Stephanie Abel, PharmD, BCPS, and Megan Mitchell, PharmD, MS, discuss pharmacist roles in combating biases, fostering collaboration with prescribers, and implementing strategies for effective opioid stewardship.
February 1, 2024
A panel of experts share insights on overcoming challenges in responsible opioid prescribing and explore emotional responses, aversion to change, and the role of interdisciplinary collaboration in addressing the opioid crisis.
January 25, 2024
Psychotherapy is comparable to pharmacotherapy for treating depression in patients with heart failure and may result in less morbidity, a new trial shows.
January 25, 2024
Initiative provides personalized care, convenience for patients with complex medical conditions
January 25, 2024
Expert colleagues explore responsible opioid management strategies and discuss addressing biases affecting prescribing practices across demographics and replacing stigmatizing language to improve patient outcomes; they also review practical approaches to creating ethical, equitable, and patient-centered opioid stewardship programs.
January 24, 2024
Easing out-of-pocket expenses for preventive medications for peripheral arterial disease could help improve adherence and health outcomes.
January 18, 2024
Ozempic may not yet be cost-effective, according to a modeling study that compared the drug with surgery.
January 10, 2024
Novo Nordisk's CEO said on Tuesday he expects patients will stick with the company's popular obesity drug Wegovy for far longer than those using older...
January 8, 2024
Zolpidem and behavior therapy each reduce daytime symptoms of insomnia such as fatigue, functional impairments, and depressive symptoms, data suggested.